Finanznachrichten46m
Cytokinetics, Incorporated: Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089
Advancement of Fast Skeletal Muscle Troponin Activator Expands Pipeline of Muscle-Directed Drug Candidates SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated ...
Business Insider1h
Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089
Advancement of Fast Skeletal Muscle Troponin Activator Expands Pipeline of Muscle-Directed Drug Candidates SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated ...
STAT4h
Cardiovascular health disparities persist in puzzling ways, studies find
New studies to be presented at the American Heart Association meeting focus on disparities in Wegovy prescriptions and ...
Business Insider9h
Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein
About the APEX Phase 2 Clinical Trial for TX45 in Pulmonary Hypertension with HFpEF TX45 is being evaluated in the APEX Phase 2 clinical trial (NCT06616974) in patients with Group 2 Pulmonary ...